StockWatch
·

AAREY DRUGS & PHARMACEUTICALS LTD. Q3 FY25 Results

AAREYDRUGSQ3 FY25 Results
Filing
MetricValue ( Cr)vs Q2 FY25
Revenue133.7927.2%
Total Income134.4727.9%
Expenditure133.0728.7%
PBT1.4019.8%
Net Profit0.7255.0%
OPM-0.57%0.31pp
NPM0.53%0.99pp
EPS0.2654.4%
View full financials

Informational and educational content only. Not investment advice.